Deciphering the Roles of TSLP, TL1A, and OX40 Signaling Pathways in Inflammatory Diseases: Advancing Discovery with Biochemical and Cellular Research Tools
In this presentation, Vanda Lopes, PhD, BPS Bioscience Product Manager, covers the TSLP, TL1A and OX40 signaling pathways, and recent advances in therapeutic modalities for the treatment of inflammatory diseases targeting these pathways. In addition, we introduce innovative biochemical and cellular tools designed to support scientific discovery in the field.
For more information on BPS’s range Inflammatory Diseases, check out their Autoimmunity products here.